About Nivagen Pharmaceuticals
Nivagen Pharmaceuticals is a private company based in Sacramento, California. It has reported $30,966,467 raised in three offerings on Form D since September 2017. Its chief executive is Jwalant Shukla.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 16, 2023 | Aug 11, 2023 | $5,000,005fully sold | 1 | $5.0M | EquityRule 506(b) | Form D ↗ |
| May 15, 2020 | May 20, 2020 | $15,966,462fully sold | 7 | $2.2M | EquityRule 506(b) | Form D ↗ |
| Sep 7, 2017 | Sep 14, 2017 | $10,000,000fully sold | 1 | $10.0M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $30,966,467 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Nivagen Pharmaceuticals's Form D filed Aug 11, 2023.
DL
Dasaradhi Lakkaraju
Executive officer
First appears on the Form D that Nivagen Pharmaceuticals filed on August 11, 2023; on 1 of its 3 filings.
JM
Jaswinder Matharu
Director
First appears on the Form D that Nivagen Pharmaceuticals filed on May 20, 2020; on 2 of its 3 filings.
GP
Gopal Patel
Executive officer
First appears on the Form D that Nivagen Pharmaceuticals filed on August 11, 2023; on 1 of its 3 filings.
JS
Jwalant Shukla
CEO and director
On every Form D that Nivagen Pharmaceuticals has filed: 3 filings, from Sep 14, 2017 to Aug 11, 2023.
RH
Rob Hart
Director
First appears on the Form D that Nivagen Pharmaceuticals filed on May 20, 2020; on 2 of its 3 filings.
AS
Ashish Sevak
Director
On every Form D that Nivagen Pharmaceuticals has filed: 3 filings, from Sep 14, 2017 to Aug 11, 2023.
PD
Praneel Deo
Executive officer
First appears on the Form D that Nivagen Pharmaceuticals filed on August 11, 2023; on 1 of its 3 filings.
MK
Michael Kulper
Director
First appears on the Form D that Nivagen Pharmaceuticals filed on August 11, 2023; on 1 of its 3 filings.
Earlier filings also listed
- Bikramjit Singh · directorLast listed on the Form D that Nivagen Pharmaceuticals filed on May 20, 2020; on 1 of its 3 filings.
- Sharad Dadbhawala · directorLast listed on the Form D that Nivagen Pharmaceuticals filed on September 14, 2017; on 1 of its 3 filings.
- Bikram Singh · directorLast listed on the Form D that Nivagen Pharmaceuticals filed on September 14, 2017; on 1 of its 3 filings.